(JHX) James Hardie Industries - Ratings and Ratios
Fiber Cement, Siding, Trim, Gypsum Boards, Cement Boards
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 44.1% |
| Value at Risk 5%th | 62.1% |
| Relative Tail Risk | -14.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.34 |
| Alpha | -44.64 |
| CAGR/Max DD | 0.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.715 |
| Beta | 1.135 |
| Beta Downside | 0.922 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.26% |
| Mean DD | 21.33% |
| Median DD | 17.00% |
Description: JHX James Hardie Industries January 03, 2026
James Hardie Industries plc (NYSE:JHX) manufactures and sells fiber cement, fiber gypsum, and cement-bonded boards across the United States, Australia, Europe, and New Zealand, operating under three geographic segments: North America Fiber Cement, Asia-Pacific Fiber Cement, and Europe Building Products.
The company’s product portfolio, marketed under the Hardie™ brand (e.g., Hardie Plank, Hardie Panel, Hardie Trim) and the fermacell and AESTUVER brands, serves both exterior applications-siding, cladding, soffit, trim-and interior uses such as walls, floors, ceilings, and fire-protection systems.
Key recent metrics: FY 2023 revenue reached approximately $2.1 billion, with an adjusted EBITDA margin of roughly 15 %; net debt/EBITDA stood at about 1.2×, indicating moderate leverage. The company reaffirmed FY 2024 revenue guidance of $2.2-$2.3 billion, driven by strong demand in the U.S. residential market.
Economic and sector drivers: (1) U.S. single-family housing starts, which have risen 8 % YoY, directly boost Hardie’s North American segment; (2) increasingly stringent building-code requirements for fire-resistant and moisture-durable materials favor fiber cement over traditional wood siding; (3) supply-chain constraints on timber and steel have shifted remodel and new-construction projects toward fiber-based alternatives.
For a deeper dive into Hardie’s valuation metrics and scenario analysis, see the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 192.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -5.47 > 1.0 |
| NWC/Revenue: 21.78% < 20% (prev 18.59%; Δ 3.19% < -1%) |
| CFO/TA 0.05 > 3% & CFO 693.5m > Net Income 192.1m |
| Net Debt (4.66b) to EBITDA (734.8m): 6.34 < 3 |
| Current Ratio: 1.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (577.4m) vs 12m ago 33.56% < -2% |
| Gross Margin: 36.27% > 18% (prev 0.40%; Δ 3587 % > 0.5%) |
| Asset Turnover: 43.24% > 50% (prev 79.14%; Δ -35.90% > 0%) |
| Interest Coverage Ratio: 3.42 > 6 (EBITDA TTM 734.8m / Interest Expense TTM 128.0m) |
Altman Z'' 1.40
| A: 0.06 (Total Current Assets 2.03b - Total Current Liabilities 1.13b) / Total Assets 14.07b |
| B: 0.12 (Retained Earnings 1.73b / Total Assets 14.07b) |
| C: 0.05 (EBIT TTM 437.4m / Avg Total Assets 9.52b) |
| D: 0.26 (Book Value of Equity 2.02b / Total Liabilities 7.75b) |
| Altman-Z'' Score: 1.40 = BB |
Beneish M -2.13
| DSRI: 1.01 (Receivables 368.0m/346.8m, Revenue 4.12b/3.94b) |
| GMI: 1.11 (GM 36.27% / 40.17%) |
| AQI: 2.33 (AQ_t 0.63 / AQ_t-1 0.27) |
| SGI: 1.05 (Revenue 4.12b / 3.94b) |
| TATA: -0.04 (NI 192.1m - CFO 693.5m) / TA 14.07b) |
| Beneish M-Score: -2.13 (Cap -4..+1) = BB |
ValueRay F-Score (Strict, 0-100) 48.63
| 1. Piotroski: 3.50pt |
| 2. FCF Yield: 1.58% |
| 3. FCF Margin: 7.23% |
| 4. Debt/Equity: 0.83 |
| 5. Debt/Ebitda: 6.34 |
| 6. ROIC - WACC: -2.52% |
| 7. RoE: 5.98% |
| 8. Revenue Trend: 39.99% |
| 9. EPS Trend: -49.63% |
What is the price of JHX shares?
Over the past week, the price has changed by +5.56%, over one month by +16.49%, over three months by +11.51% and over the past year by -29.04%.
Is JHX a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the JHX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.6 | 12.8% |
| Analysts Target Price | 27.6 | 12.8% |
| ValueRay Target Price | 25.1 | 2.4% |
JHX Fundamental Data Overview January 25, 2026
P/E Forward = 19.6078
P/S = 3.4526
P/B = 2.2483
P/EG = 2.5263
Revenue TTM = 4.12b USD
EBIT TTM = 437.4m USD
EBITDA TTM = 734.8m USD
Long Term Debt = 4.97b USD (from longTermDebt, last quarter)
Short Term Debt = 77.0m USD (from shortTermDebt, last quarter)
Debt = 5.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.66b USD (from netDebt column, last quarter)
Enterprise Value = 18.89b USD (14.21b + Debt 5.24b - CCE 566.7m)
Interest Coverage Ratio = 3.42 (Ebit TTM 437.4m / Interest Expense TTM 128.0m)
EV/FCF = 63.46x (Enterprise Value 18.89b / FCF TTM 297.7m)
FCF Yield = 1.58% (FCF TTM 297.7m / Enterprise Value 18.89b)
FCF Margin = 7.23% (FCF TTM 297.7m / Revenue TTM 4.12b)
Net Margin = 4.67% (Net Income TTM 192.1m / Revenue TTM 4.12b)
Gross Margin = 36.27% ((Revenue TTM 4.12b - Cost of Revenue TTM 2.62b) / Revenue TTM)
Gross Margin QoQ = 32.59% (prev 37.44%)
Tobins Q-Ratio = 1.34 (Enterprise Value 18.89b / Total Assets 14.07b)
Interest Expense / Debt = 1.29% (Interest Expense 67.8m / Debt 5.24b)
Taxrate = 34.30% (221.4m / 645.4m)
NOPAT = 287.4m (EBIT 437.4m * (1 - 34.30%))
Current Ratio = 1.79 (Total Current Assets 2.03b / Total Current Liabilities 1.13b)
Debt / Equity = 0.83 (Debt 5.24b / totalStockholderEquity, last quarter 6.32b)
Debt / EBITDA = 6.34 (Net Debt 4.66b / EBITDA 734.8m)
Debt / FCF = 15.64 (Net Debt 4.66b / FCF TTM 297.7m)
Total Stockholder Equity = 3.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.02% (Net Income 192.1m / Total Assets 14.07b)
RoE = 5.98% (Net Income TTM 192.1m / Total Stockholder Equity 3.21b)
RoCE = 5.35% (EBIT 437.4m / Capital Employed (Equity 3.21b + L.T.Debt 4.97b))
RoIC = 5.08% (NOPAT 287.4m / Invested Capital 5.65b)
WACC = 7.61% (E(14.21b)/V(19.46b) * Re(10.10%) + D(5.24b)/V(19.46b) * Rd(1.29%) * (1-Tc(0.34)))
Discount Rate = 10.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.58%
[DCF Debug] Terminal Value 79.08% ; FCFF base≈329.6m ; Y1≈318.6m ; Y5≈315.1m
Fair Price DCF = 2.38 (EV 6.04b - Net Debt 4.66b = Equity 1.38b / Shares 579.9m; r=7.61% [WACC]; 5y FCF grow -4.56% → 2.90% )
EPS Correlation: -49.63 | EPS CAGR: -7.62% | SUE: 0.08 | # QB: 0
Revenue Correlation: 39.99 | Revenue CAGR: 10.13% | SUE: 0.02 | # QB: 0
EPS current Year (2026-03-31): EPS=1.10 | Chg30d=+0.000 | Revisions Net=+3 | Growth EPS=-10.9% | Growth Revenue=+23.7%
EPS next Year (2027-03-31): EPS=1.19 | Chg30d=+0.000 | Revisions Net=+3 | Growth EPS=+8.2% | Growth Revenue=+15.0%
Additional Sources for JHX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle